Novo Nordisk A/S | Rentekostnader



Interest Expense On Debt Endring Dato
Bausch Health Companies USD 346M 4M 2024-09
Bristol-Myers Squibb USD 496M 9M 2024-12
Eli Lilly USD 224.7M 78.4M 2024-12
GlaxoSmithKline 173M 17M 2024-12
Merck USD 328M 2M 2024-12
Novartis USD 275M 11M 2024-12
Novo Nordisk 562M 40M 2024-09
Pacira USD 4.68M 9K 2024-12
Sanofi 62M 17M 2024-12
Supernus Pharmaceuticals USD 0 0 2024-12



Novo Nordisk A/S Rentekostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.